Analyst Ratings for Inmed Pharmaceuticals (INM)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/16/2022 | Roth/MKM | Scott Henry | Upgrade | Buy (Neutral) |
0.80 (6.00) |
0.83 (0.92) |
10.84% | Details |
| 11/29/2021 | H.C. Wainwright | Raghuram Selvaraju | New Coverage | Buy (N/A) |
6.00 (N/A) |
1.68 (0.92) |
-45.24% | Details |
